🇺🇸 United States Country × Condition
alzheimer disease Clinical Trials in United States
Active clinical trials for alzheimer disease with research sites in United States. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 24 // Recruiting: 24 Phases: Phase 2, Phase 3 // Updated: Daily
Total Trials
24
Recruiting Now
24
Country
🇺🇸 United States
Active Trials in United States (24)
NCT06808984 Phase 2
Recruiting
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
Enrollment
120 pts
Country
🇺🇸 United States
Celgene
View Trial → NCT03657745
Recruiting
Alzheimer's Disease Treatment With Combination of 40Hz Light and Cognitive Therapy
Enrollment
2,000 pts
Country
🇺🇸 United States
Alzheimer's Light LLC
View Trial → NCT06937229 Phase 3
Recruiting
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
Enrollment
600 pts
Country
🇺🇸 United States
Bristol-Myers Squibb
View Trial → NCT05984524
Recruiting
Gamma-Music Based Intervention for Mild Alzheimer's Disease
Enrollment
60 pts
Country
🇺🇸 United States
Northeastern University
View Trial → NCT06096090 Phase 2
Recruiting
Phase II Clinical Trial of Interleukin-2 in AD
Enrollment
40 pts
Country
🇺🇸 United States
The Methodist Hospital Research Ins...
View Trial → NCT05456503 Phase 3
Recruiting
PET Imaging Tau Accumulation in FTLD and Atypical Alzheimer's Using [18F]-PI-2620
Enrollment
72 pts
Country
🇺🇸 United States
University of Pennsylvania
View Trial → NCT05206305
Recruiting
Sensory-Evoked Cortical Gamma Oscillation
Enrollment
20 pts
Country
🇺🇸 United States
University of Tennessee Medical Cen...
View Trial → NCT05741853
Recruiting
Cognitive Reserve and Response to Speech-Language Intervention in Bilingual Speakers With Primary Progressive Aphasia
Enrollment
60 pts
Country
🇺🇸 United States
University of Texas at Austin
View Trial → NCT03507257
Recruiting
Longitudinal Early-onset Alzheimer's Disease Study Protocol
Enrollment
850 pts
Country
🇺🇸 United States
Indiana University
View Trial → NCT06639282 Phase 2
Recruiting
Repurposing Siponimod for Alzheimer's Disease
Enrollment
105 pts
Country
🇺🇸 United States
St. Joseph's Hospital and Medical C...
View Trial → NCT05010603
Recruiting
Late Onset Alzheimer's Disease
Enrollment
10,000 pts
Country
🇺🇸 United States
Columbia University
View Trial → NCT03671889
Recruiting
ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's Disease
Enrollment
50 pts
Country
🇺🇸 United States
InSightec
View Trial → NCT05929703
Recruiting
Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders
Enrollment
1,900 pts
Country
🇺🇸 United States
University of Michigan
View Trial → NCT04114994
Recruiting
Longitudinal Cognitive Assessment by BoCA
Enrollment
10,000 pts
Country
🇺🇸 United States
Alzheimer's Light LLC
View Trial → NCT05574634
Recruiting
The Role of the Locus Coeruleus in Age-related Distractibility
Enrollment
200 pts
Country
🇺🇸 United States
Virginia Polytechnic Institute and ...
View Trial → NCT05655195
Recruiting
Chronic Treatment of Alzheimer's Disease by Gamma Light and Sound Therapy
Enrollment
50 pts
Country
🇺🇸 United States
Massachusetts Institute of Technolo...
View Trial → NCT06397339
Recruiting
Indian Transforming Alzheimer's Care Training (INTACT)
Enrollment
28 pts
Country
🇺🇸 United States
Washington State University
View Trial → NCT06728436
Recruiting
Testing the Effects of a Text Message Caregiver Support Intervention for Latinos
Enrollment
288 pts
Country
🇺🇸 United States
University of Kansas Medical Center
View Trial → NCT03672266
Recruiting
Studies of Brain and Body Interaction
Enrollment
100 pts
Country
🇺🇸 United States
Rutgers University
View Trial → NCT06930560
Recruiting
HEARS-NPS: Addressing Hearing Loss as a Common Unmet Contributor of Neuropsychiatric Symptoms
Enrollment
300 pts
Country
🇺🇸 United States
Johns Hopkins University
View Trial → NCT05904132
Recruiting
Individual Closed-Loop Neuromodulation Therapy for Alzheimer's Disease
Enrollment
70 pts
Country
🇺🇸 United States
Massachusetts General Hospital
View Trial → NCT06511752 EARLY_Phase 1
Recruiting
Educational Support Group Program for Bilingual and Spanish-speaking Carepartners and People With Progressive Aphasia
Enrollment
120 pts
Country
🇺🇸 United States
University of Texas at Austin
View Trial → NCT04075435 EARLY_Phase 1
Recruiting
Cannabidiol Solution for the Treatment of Behavioral Symptoms in Older Adults With Mild Cognitive Impairment or Alzheimer's Dementia
Enrollment
12 pts
Country
🇺🇸 United States
Mclean Hospital
View Trial → NCT05139290
Recruiting
DECIDE: Dyads and Families
Enrollment
40 pts
Country
🇺🇸 United States
Emory University
View Trial → Frequently Asked Questions
How many alzheimer disease clinical trials are active in United States?
There are currently 24 active clinical trials for alzheimer disease with sites in United States, of which 24 are actively recruiting patients.
How can I join a alzheimer disease clinical trial in United States?
To join a alzheimer disease clinical trial in United States, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in United States directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are alzheimer disease trials in United States?
Active alzheimer disease trials in United States span Phase 2, Phase 3, EARLY_Phase 1. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.